In todays episode we have updates for your from the FDA on approval of Uplizna for NMOSD, Zepzelca for metastatic small cell lung cancer, and new indications for Tivicay and Ilaris. Don't forget to like, share, and subscribe - Enjoy!

Hey everyone! Thanks for listening today - this episode we do have updates from the FDA including approval of Zilxi for rosacea, and approval of Oriahnn for uterine fibroids. We also will discuss a new indication for AstraZenecas Brilinta. Don't forget to like, share, and subscribe wherever you listen to your podcasts! Enjoy!

This week we do have a few products that were approved with new indications. We have updates for you from the FDA on a new indication for Pomalyst for Kaposi sarcoma and approval of Kynmobi to treat off-episodes in Parkinsons disease. And also this week, approval of the combination Opdivo and Yervoy for mNSCLC with PD-L1 expression. Don't forget to like, share, and subscribe! Enjoy!

In this weeks episode we have updates for you from the FDA on approval of Retevmo, for multiple types of cancer and approval of Qinlock for gastrointestinal stromal tumors. We also have new indications to talk about with Rubraca and Lynparza, and we’ll also be giving our regular update on coronavirus numbers to date. Don't forget to like, share, & subscribe! Enjoy!

This is our continuation for Part 2 of this weeks episode where we have updates for you from the FDA for approval of Tabrecta for non small cell lung cancer and approval of Farxiga as a stand alone agent for the treatment of heart failure in adults. We'll also be giving our regular update on coronavirus numbers to date. Feel free to like, share, and subscribe. Enjoy!

This episode we have updates for you from the FDA for approval of Ongentys for Parkinson’s symptoms and approval of the MenQuadfi vaccine, a meningococcal conjugate vaccine. We also have new indication and age approvals for Zejula for ovarian cancer, Jublia for onychomychosis, and Keytruda for multiple types of cancer. We'll be giving our regular update on coronavirus numbers in the next episode this week. Don't forget to like, share, and subscribe! Enjoy!

This week we have updates for you from the FDA for approval of Pemazyre for the treatment of cholangiocarcinoma and new indications approved for Imbruvica and Trodelvy. We'll also be giving an update on the coronavirus epidemic and flu season to date. Don't forget to like, share, and subscribe! Enjoy!

In this week's episode we have updates for you from the FDA for approval of Jelmyto for the treatment of urothelial cancer and Tukysa in combination with other chemotherapy for the treatment of HER2 positive breast cancer. We'll also be giving an update on the coronavirus epidemic and flu season to date. Don't forget to like, share, and subscribe! Enjoy!

In this episode we go over FDA approval of Koselugo for the treatment of pediatric patients with neurofibromatosis type 1, as well as new indications for Reblozyl and Braftovi. We’ll also talk about the most recent ranitidine recall and as usual, we'll be giving an update on the coronavirus epidemic and flu season to date, including an expanded scope for pharmacists to actually administer COVID19 tests. Don't forget to like, share, and subscribe! Enjoy!

In this episode we go over FDA approval of Sevenfact for Hemophilia, and added indications for Imfinzi, Taltz, and Eucrisa. And we’ll be giving our usual update on the novel coronavirus and flu season to date including FDA giving emergency use authorization for hydroxychloroquine and chloroquine. Don't forget to like, share, and subscribe! Enjoy!